Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 346 AL 360

How Gut Microbiota Influence Healthy Aging: Overview of Reviews

Todmal TG, Bibi R, Cangelosi G, Panella M, Masini A.

Geriatrics (Basel). 2026 Aug 17;11(4):107. doi: 10.3390/geriatrics11040107.

Ultraviolet radiation and neurodegeneration: molecular mechanisms underlying dual neuroprotective and neurotoxic effects

Praharaj S, Chakraborty E, Mahalingam G.

Front Cell Neurosci. 2026 Aug 13;20:1909393. doi: 10.3389/fncel.2026.1909393. eCollection 2026.

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives

Gapińska N, Abram M, Jakubiec M, Rafało-Ulińska A, Szewczyk B, Kamiński K, Wlaź P, Socała K.

Pharmacol Ther. 2026 Aug 29;288:109106. doi: 10.1016/j.pharmthera.2026.109106. Online ahead of print.

From Mouth to Mind: Unraveling the Oral Microbiome's Role in Orofacial Pain and Neurodegeneration

Moses S, Phulambrikar T, Dosi T.

J Clin Pract Res. 2026 Jul 20;48(4):356-367. doi: 10.14744/cpr.2026.15313. eCollection 2026 Aug.

Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025

Carella A, Carroll KC, Munson E.

J Clin Microbiol. 2026 Oct 14;64(10):e0097326. doi: 10.1128/jcm.00973-26. Epub 2026 Sep 4.

Deep Brain Stimulation: A Window Into the Neural Mechanisms of Latent Nystagmus

Agharazi H, Guha A, Shaikh AG, Ghasia FF.

Invest Ophthalmol Vis Sci. 2026 Sep 1;67(11):33. doi: 10.1167/iovs.67.11.33.

The Therapeutic Potential of Purmorphamine Across Disease Models

Dhar A, Sharar AD, Papisetty S, Bydon M, Moinuddin FM.

J Cell Mol Med. 2026 Sep;30(17):e71349. doi: 10.1111/jcmm.71349.

Dysregulated polyamine metabolism in neurological disorders: molecular mechanisms and therapeutic opportunities

Li K, Si Q, Zhang C, Zhang C, Wang M, Liu J, Zhao J, Xing H, Liu J.

Mol Biol Rep. 2026 Sep 22;53(1):1602. doi: 10.1007/s11033-026-12774-y.

RNA m6A demethylase FTO in central nervous system disorders: Mechanisms and therapeutic implications

Bi H, Sun M, Ma Q, Li X, Wang Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Oct 2;150:111942. doi: 10.1016/j.pnpbp.2026.111942. Epub 2026 Sep 25.

Epigenetic drift and LINE-1 activation in aging brain: Implications for neurodegenerative disease

Armoundas AA, Piperi C.

Mech Ageing Dev. 2026 Oct;233:112235. doi: 10.1016/j.mad.2026.112235. Epub 2026 Aug 11.

Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets

Yang D, Wu X, Luo X, Teng Y, Duan X, Kang T, Wu W.

Biomed Chromatogr. 2026 Sep;40(9):e70560. doi: 10.1002/bmc.70560.

Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025

Bi Q, Zhang L, Zhang J, Wang X, Zuo C, Zhao S, Wang Z, Zhao Z, Wan H.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Sep;399(12):19949-19971. doi: 10.1007/s00210-026-05635-9. Epub 2026 Jul 1.

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts

Barbosa R, Bastos P, Rascol O, Corvol JC, Fabienne OM, Brefel-Courbon C, Leung C, Mariani LL, Defebvre L, Carriere N, Giordana C, Heraud C, Laurencin C, Prange S, Remy P, Hopes L, Houeto JL, Prin P, Thiriez C, De Maindreville AD, Benatru I, Corbille AG, di Legge S, Lagha-Boukbiza O, Schneider V, Grimaldi S, Castelnovo G, Tir M, Maltête D, Foubert-Samier A, Marques A, Drapier S, Fabbri M; French NS-Park network.

Neurology. 2026 Oct 13;107(7):e218515. doi: 10.1212/WNL.0000000000218515. Epub 2026 Sep 9.

Oxidative Stress: The Role of Aluminum Ions in Copper Homeostasis Within the Neurons

Lv Q, Huang S, Li Y, Li Y.

J Appl Toxicol. 2026 Sep 1. doi: 10.1002/jat.70412. Online ahead of print.

Advanced Eye Movement Features Measured by Quantitative Oculography as Candidate Biomarkers for Progressive Supranuclear Palsy

Ouyang H, Liu B, Peng Q, Ma Z, Tang Z, Chang A, Liu M, Cao X, Xu Y, Xia Y.

Diagnostics (Basel). 2026 Sep 11;16(18):2944. doi: 10.3390/diagnostics16182944.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias